Loomis, Sayles & Company’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,560,057
| Closed | -$58.2M | – | 950 |
|
|
2021
Q2 | $58.2M | Sell |
1,560,057
-31,511
| -2% | -$1.18M | 0.07% | 124 |
|
|
2021
Q1 | $40.7M | Buy |
1,591,568
+220,296
| +16% | +$5.63M | 0.05% | 186 |
|
|
2020
Q4 | $30.2M | Buy |
1,371,272
+312,817
| +30% | +$6.89M | 0.04% | 204 |
|
|
2020
Q3 | $19M | Buy |
1,058,455
+333,452
| +46% | +$6M | 0.03% | 243 |
|
|
2020
Q2 | $18.4M | Buy |
+725,003
| New | +$18.4M | 0.03% | 229 |
|